CNY 12.68
(0.96%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -3.15 Billion CNY | -7.46% |
2022 | -2.93 Billion CNY | 59.08% |
2021 | -7.17 Billion CNY | -11.7% |
2020 | -6.42 Billion CNY | 27.82% |
2019 | -8.89 Billion CNY | -979.58% |
2018 | 1.01 Billion CNY | 125.7% |
2017 | 448.05 Million CNY | 349.6% |
2016 | 99.65 Million CNY | -57.84% |
2015 | 236.4 Million CNY | 355.76% |
2014 | -92.43 Million CNY | -488.86% |
2013 | -15.69 Million CNY | 95.75% |
2012 | -369.35 Million CNY | -12.14% |
2011 | -329.37 Million CNY | 50.21% |
2010 | -661.59 Million CNY | -898.58% |
2009 | -66.25 Million CNY | -50.77% |
2008 | -43.94 Million CNY | 72.86% |
2007 | -161.92 Million CNY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -5.51 Billion CNY | -75.02% |
2024 Q2 | -794.02 Million CNY | 85.62% |
2024 Q3 | -1.91 Billion CNY | -109.16% |
2023 Q2 | 40.83 Million CNY | -96.93% |
2023 Q3 | -281.84 Million CNY | -790.23% |
2023 FY | -3.15 Billion CNY | -7.46% |
2023 Q4 | -3.15 Billion CNY | -1018.98% |
2023 Q1 | 1.32 Billion CNY | 145.29% |
2022 Q3 | -3.71 Billion CNY | -185.2% |
2022 FY | -2.93 Billion CNY | 59.08% |
2022 Q4 | -2.93 Billion CNY | 20.93% |
2022 Q2 | -1.3 Billion CNY | 7.32% |
2022 Q1 | -1.4 Billion CNY | 66.66% |
2021 FY | -7.17 Billion CNY | -11.7% |
2021 Q3 | -1.8 Billion CNY | 59.67% |
2021 Q1 | -1.62 Billion CNY | 74.65% |
2021 Q4 | -4.21 Billion CNY | -133.4% |
2021 Q2 | -4.47 Billion CNY | -174.9% |
2020 Q2 | -4.89 Billion CNY | 10.15% |
2020 Q4 | -6.42 Billion CNY | 12.7% |
2020 FY | -6.42 Billion CNY | 27.82% |
2020 Q1 | -5.44 Billion CNY | 38.73% |
2020 Q3 | -7.35 Billion CNY | -50.2% |
2019 FY | -8.89 Billion CNY | -979.58% |
2019 Q3 | -2.94 Billion CNY | -33.65% |
2019 Q4 | -8.89 Billion CNY | -202.46% |
2019 Q2 | -2.2 Billion CNY | -30.15% |
2019 Q1 | -1.69 Billion CNY | -292.77% |
2018 Q4 | 877.04 Million CNY | -0.55% |
2018 Q1 | 196.73 Million CNY | 4.95% |
2018 FY | 1.01 Billion CNY | 125.7% |
2018 Q3 | 881.9 Million CNY | 23.14% |
2018 Q2 | 716.15 Million CNY | 264.01% |
2017 Q2 | 59.08 Million CNY | -13.1% |
2017 Q3 | 171.05 Million CNY | 189.5% |
2017 Q4 | 187.46 Million CNY | 9.6% |
2017 Q1 | 67.98 Million CNY | -31.78% |
2017 FY | 448.05 Million CNY | 349.6% |
2016 Q4 | 99.65 Million CNY | -62.71% |
2016 FY | 99.65 Million CNY | -57.84% |
2016 Q2 | 219.13 Million CNY | -35.79% |
2016 Q3 | 267.25 Million CNY | 21.96% |
2016 Q1 | 341.25 Million CNY | 44.35% |
2015 Q2 | 73.95 Million CNY | -19.69% |
2015 FY | 236.4 Million CNY | 355.76% |
2015 Q4 | 236.4 Million CNY | 50.43% |
2015 Q3 | 157.15 Million CNY | 112.49% |
2015 Q1 | 92.09 Million CNY | 199.64% |
2014 Q2 | 237.41 Million CNY | 53.92% |
2014 Q4 | -92.43 Million CNY | -124.38% |
2014 FY | -92.43 Million CNY | -488.86% |
2014 Q1 | 154.24 Million CNY | 1082.68% |
2014 Q3 | 379.16 Million CNY | 59.71% |
2013 Q2 | -194.3 Million CNY | 11.69% |
2013 Q1 | -220.04 Million CNY | 40.43% |
2013 Q4 | -15.69 Million CNY | 69.77% |
2013 FY | -15.69 Million CNY | 95.75% |
2013 Q3 | -51.92 Million CNY | 73.28% |
2012 Q1 | -303.65 Million CNY | 7.81% |
2012 Q2 | -367.78 Million CNY | -21.12% |
2012 Q3 | -364.87 Million CNY | 0.79% |
2012 Q4 | -369.35 Million CNY | -1.23% |
2012 FY | -369.35 Million CNY | -12.14% |
2011 Q1 | -370.6 Million CNY | 43.98% |
2011 FY | -329.37 Million CNY | 50.21% |
2011 Q4 | -329.37 Million CNY | -0.16% |
2011 Q3 | -328.86 Million CNY | 7.93% |
2011 Q2 | -357.19 Million CNY | 3.62% |
2010 FY | -661.59 Million CNY | -898.58% |
2010 Q1 | -100.25 Million CNY | -51.32% |
2010 Q3 | -788.69 Million CNY | -5.57% |
2010 Q4 | -661.59 Million CNY | 16.12% |
2010 Q2 | -747.11 Million CNY | -645.2% |
2009 Q4 | -66.25 Million CNY | 0.0% |
2009 FY | -66.25 Million CNY | -50.77% |
2008 FY | -43.94 Million CNY | 72.86% |
2007 FY | -161.92 Million CNY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Hubei Biocause Pharmaceutical Co., Ltd. | -2.73 Billion CNY | -15.324% |